Compare · head to head
Ambarella vs Pacific Biosciences of California
Ambarella ranks higher overall — 360 rank 19 vs 16.
Pacific Biosciences of California leads on Growth (54 vs 48). Ambarella leads on Safety (44 vs 30). The two are close on Value, Quality and Sentiment.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Chips & Hardware | Health Care |
| Industry | Semiconductors & Semiconductor Equipment | Life Sciences Tools & Services |
| Size | Medium | Small |
| ISIN | KYG037AX1015 | US69404D1081 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 19 | 16 |
| Value | 38 | 40 |
| Quality | 33 | 29 |
| Growth | 48 | 54 |
| Safety | 44 | 30 |
| Sentiment | 52 | 56 |
| Quality details | ||
| Profitability | 25 | 13 |
| Cash Truth | 41 | 44 |
Ambarella vs Quest DiagnosticsAmbarella vs PersonalisAmbarella vs Tango TherapeuticsAmbarella vs MedpacesAdd a third stock →
Full analyses: Ambarella · Pacific Biosciences of California
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100